Jan Jepras is a pharmacovigilance consultant with over 20 years experience of drug safety across all phases of drug development. Jan was a Pharmacovigilance Manager at GSK between 1999 and 2010 and has been an independent consultant since then working with a variety of clients both big and small including Takeda, Public Health England, The Department of Health, Pharmora, AstraZeneca, Centus Biotherapeutics, Immune System Key and Amgen. Jan is experienced in all aspects of pharmacovigilance but specializes in pharmacovigilance writing such as global drug registration submissions, risk management plans, periodic reporting, signal detection, and evaluation and training. Jan is a Fellow of The Pharmaceutical Information and Pharmacovigilance Association and lectures on Pharmacovigilance on the MSc course in Pharmaceutical Medicine at the University of Surrey.